---
title: "AAIC"
description: "AAIC Investment is the investment management arm of Asia Africa Investment & Consulting, a specialist firm focused on strategic consulting and healthcare driven investing across Asia and Africa. It manages dedicated Africa focused funds such as the Africa Healthcare Fund, targeting fast growing companies in the healthcare and innovation sectors across the continent. AAIC is an active institutional investor in African technology, with a clear emphasis on health related solutions. Based on available investment records, AAIC has participated in Seed, Series A, and Series B rounds between April 2020 and May 2026, committing approximately 51.5 million dollars across eight funding rounds. Its portfolio in Africa includes Shiprazor in South Africa, Helium Health in Nigeria, Rology and Shezlong in Egypt, Gozem in Togo, RecoMed in South Africa, and Lami in Kenya, covering health tech, logistics and supply chain, travel and mobility, and insurtech. Through these investments AAIC has built a strong presence in key African markets such as South Africa, Nigeria, Egypt, Togo, and Kenya, often investing alongside respected regional and global investors. Co investors in its African deals have included Global Ventures, Tencent, AXA Investment Managers, Capria Ventures, and other institutional and strategic backers. AAIC’s activity illustrates a consistent strategy of supporting technology enabled healthcare and adjacent services that improve access, efficiency, and financial inclusion in African health ecosystems."
canonical_url: "https://liners.com/investors/aaic"
markdown_url: "https://liners.com/investors/aaic.md"
type: "investor"
language: "en"
image: "https://assets.liners.com/storage/v1/object/public/media/investors/aaic/favicon.png?v=1785329852027"
updated_at: "2026-09-03T03:04:21.789Z"
---

# AAIC

AAIC Investment is the investment management arm of Asia Africa Investment & Consulting, a specialist firm focused on strategic consulting and healthcare driven investing across Asia and Africa. It manages dedicated Africa focused funds such as the Africa Healthcare Fund, targeting fast growing companies in the healthcare and innovation sectors across the continent. AAIC is an active institutional investor in African technology, with a clear emphasis on health related solutions. Based on available investment records, AAIC has participated in Seed, Series A, and Series B rounds between April 2020 and May 2026, committing approximately 51.5 million dollars across eight funding rounds. Its portfolio in Africa includes Shiprazor in South Africa, Helium Health in Nigeria, Rology and Shezlong in Egypt, Gozem in Togo, RecoMed in South Africa, and Lami in Kenya, covering health tech, logistics and supply chain, travel and mobility, and insurtech. Through these investments AAIC has built a strong presence in key African markets such as South Africa, Nigeria, Egypt, Togo, and Kenya, often investing alongside respected regional and global investors. Co investors in its African deals have included Global Ventures, Tencent, AXA Investment Managers, Capria Ventures, and other institutional and strategic backers. AAIC’s activity illustrates a consistent strategy of supporting technology enabled healthcare and adjacent services that improve access, efficiency, and financial inclusion in African health ecosystems.

## Breadcrumbs

- [Investors](/investors)
- [AAIC](/investors/aaic)

## Summary

AAIC Investment is the investment management arm of Asia Africa Investment & Consulting, a specialist firm focused on strategic consulting and healthcare driven investing across Asia and Africa. It manages dedicated Africa focused funds such as the Africa Healthcare Fund, targeting fast growing companies in the healthcare and innovation sectors across the continent. AAIC is an active institutional investor in African technology, with a clear emphasis on health related solutions. Based on available investment records, AAIC has participated in Seed, Series A, and Series B rounds between April 2020 and May 2026, committing approximately 51.5 million dollars across eight funding rounds. Its portfolio in Africa includes Shiprazor in South Africa, Helium Health in Nigeria, Rology and Shezlong in Egypt, Gozem in Togo, RecoMed in South Africa, and Lami in Kenya, covering health tech, logistics and supply chain, travel and mobility, and insurtech. Through these investments AAIC has built a strong presence in key African markets such as South Africa, Nigeria, Egypt, Togo, and Kenya, often investing alongside respected regional and global investors. Co investors in its African deals have included Global Ventures, Tencent, AXA Investment Managers, Capria Ventures, and other institutional and strategic backers. AAIC’s activity illustrates a consistent strategy of supporting technology enabled healthcare and adjacent services that improve access, efficiency, and financial inclusion in African health ecosystems.

This anonymous Markdown view includes only rows that are readable before the HTML sign-in gate. Use the canonical HTML page to sign in and view more.

## Recorded investments

| Product | URL | Stage | Amount | Date |
| --- | --- | --- | --- | --- |
| Shiprazor | /shiprazor | Seed | 2650000 | 2026-05-01T00:00:00.000Z |
| Helium Health | /helium-health | Series B | 30000000 | 2023-06-01T00:00:00.000Z |
| Gozem | /gozem | Series A | 5000000 | 2021-12-01T00:00:00.000Z |
| RecoMed | /recomed | Seed | 1500000 | 2021-10-01T00:00:00.000Z |
| Lami | /lami | Seed | 1800000 | 2021-05-01T00:00:00.000Z |

## Related pages

- [All investors](/investors)
- [Funding rounds](/funding)

## Access and citation

- [Canonical HTML page](https://liners.com/investors/aaic)
- [Markdown route index](/sitemap.md)
- [Agent access guide](/llms.txt)